Pharma News

India currently levies around 10 per cent import duty on American drugs, while the US doesn't charge any import duty on Indian drugs.

The UK’s National Institute for Health and Care Excellence (NICE) has issued further draft guidance reaffirming its decision not to recommend the Alzheimer’s treatments Kisunla (donane...

The FDA approved an expanded indication for furosemide injection (Furoscix; scPharmaceuticals, Inc.)

The company previously announced data from another Phase III trial of cebranopadol (developmental code GRT-6005), which also met its primary endpoint.

Oruka Therapeutics Announces Preclinical Data for ORKA-002 at the 2025 American Academy of Dermatology Annual Meeting

Ascentage Pharma said that its drug Olverembatinib is the first China-approved third-generation BCR-ABL inhibitor, and has been approved for certain chronic myeloid leukemia (CML) indications ...

CERo Therapeutics Holdings, Inc. announced that it will present preclinical data for its lead compound, CER-1236, targeting ovarian cancer during the Spring Scientific meeting of the Society for Immun...

Antengene’s new drug application (NDA) for Xpovio (selinexor) has gained approval from the Indonesia National Agency of Drug and Food Control for three indications.

Jazz Pharmaceuticals has announced a definitive agreement to acquire Chimerix, a US-based biotech firm, for approximately $935m in cash.

The Food and Drug Administration (FDA) has granted Fast Track designation to LTG-001 (Latigo Biotherapeutics, Inc.) for the treatment of acute pain.

The combined use of two well-known active substances can fight leukemic cells and limit their spread. This is the result of a study conducted by the Karl Landsteiner University of Health Sciences (...

Liege, Belgium – 4 March 2025. Allegro NV, a biomedical company developing a transformative nanotechnology-based treatment for degenerative joint disease, announced today that hydrocelin (ALG-00...